Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

MicroPort EP MedTech obtains CE Mark approval for Columbus 3D EP navigation system

Shanghai MicroPort EP MedTech, a wholly-owned subsidiary of Shanghai MicroPort Medical Group, has obtained CE Mark approval for its Columbus 3D EP navigation system, indicated for the diagnosis and treatment of complex arrhythmia diseases.

Developed by MicroPort EP Medtech and Anchor External Reference Patch, the Columbus EP navigation system processes the localization information of the catheter and then generates 3D of heart chambers.

A further detailed electroanatomical model is generated after combining the model with electrocardiography reading.

Columbus provides a comprehensive image solution that combines cardiac electrical mapping with anatomy structure for physicians to better treat patients with complex arrhythmias, while reducing the exposure to x-rays during the procedures.

MicroPort EP MedTech president Dr Yiyong Sun noted in addition to typical functions offered by competitors’ products, Columbus provides real time display of the deflected portion of the ablation catheter.

"By incorporating multi-channel EP recording functions, Columbus™ provides physicians with benefit of real-time observation and analysis of intraoperative electrical signal change. The receipt of CE registration of Columbus™ is a great advancement of MicroPort EP business," Dr Sun added.

Complex arrhythmia diseases includes supraventricular tachycardia, atrial fibrillation, atrial flutter, atrial tachycardia, premature ventricular contractions and ventricular tachycardia

MicroPort EP Medtech is preparing to introduce its electrophysiology products into the international market.